We are excited to announce the launch of our latest innovation in cell and gene therapy:
An endonuclease from Serratia marcescens produced in E. coli, cleaving a wide range of DNA and RNA substrates. The product is designed for use in the purification of viral vectors, oncolytic viruses and viral vaccines to digest the nucleic acids in the harvest.
High quality
Attractive pricing
Source from a strong partner for robust supply
Regulatory disclaimer:
Pre-launch sample: Intended for evaluation purposes.
Final product: For further processing into medical devices, IVD and pharmaceutical products only.
Warranty limitation:
It is the sole responsibility of the customer to determine the suitability of all raw materials, products and components in order to ensure that the final end-use product is safe for its end use; performs or functions as intended; and complies with all applicable legal and regulatory requirements. Roche makes no representations or warranties of any kind regarding the Product, express or implied, other than those expressly set forth in the terms and conditions of sale (if any), and disclaims all implied or statutory warranties including warranty of merchantability and fitness for a particular purpose.
